Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of LAS41008 vs Fumaderm in Healthy Subjects
NCT02955693Phase 1Completed
- Sponsor
- Almirall
- Start
- Sep 2016
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dimethyl fumarate in plaque psoriasis (4 arms), sponsored by Almirall. Primary endpoints: Area under the concentration-time curve from zero to time t, Maximum plasma concentration and 2 more. Started Sep 2016; status: completed.
02
Drugs
dimethyl fumarate
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02955693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02955693.